These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33771279)

  • 21. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial.
    Mills KL; Teesson M; Back SE; Brady KT; Baker AL; Hopwood S; Sannibale C; Barrett EL; Merz S; Rosenfeld J; Ewer PL
    JAMA; 2012 Aug; 308(7):690-9. PubMed ID: 22893166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
    Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
    JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders.
    Sannibale C; Teesson M; Creamer M; Sitharthan T; Bryant RA; Sutherland K; Taylor K; Bostock-Matusko D; Visser A; Peek-O'Leary M
    Addiction; 2013 Aug; 108(8):1397-1410. PubMed ID: 25328957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resting-state connectivity subtype of comorbid PTSD and alcohol use disorder moderates improvement from integrated prolonged exposure therapy in Veterans.
    Stout DM; Harlé KM; Norman SB; Simmons AN; Spadoni AD
    Psychol Med; 2023 Jan; 53(2):332-341. PubMed ID: 33926595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Written exposure therapy for veterans with co-occurring substance use disorders and PTSD: Study design of a randomized clinical trial.
    Meshberg-Cohen S; Cook JM; Bin-Mahfouz A; Petrakis IL
    Contemp Clin Trials; 2024 Apr; 139():107475. PubMed ID: 38365173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders.
    Badour CL; Flanagan JC; Allan NP; Gilmore AK; Gros DF; Killeen T; Korte KJ; Brown DG; Kolnogorova K; Back SE
    J Trauma Stress; 2022 Apr; 35(2):546-558. PubMed ID: 34773928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Randomized Controlled Trial for Veterans with PTSD and Substance Use Disorder: Creating Change versus Seeking Safety.
    Najavits LM; Krinsley K; Waring ME; Gallagher MW; Skidmore C
    Subst Use Misuse; 2018 Sep; 53(11):1788-1800. PubMed ID: 29461920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binge drinking following residential treatment for posttraumatic stress disorder among veterans with and without alcohol use disorder.
    Meshberg-Cohen S; Gross GM; Kachadourian LK; Harpaz-Rotem I
    J Psychiatr Res; 2021 Nov; 143():202-208. PubMed ID: 34500350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment.
    Brown DG; Flanagan JC; Jarnecke A; Killeen TK; Back SE
    J Ethn Subst Abuse; 2022; 21(3):1141-1164. PubMed ID: 33111647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in positive and negative affect following prolonged exposure for PTSD comorbid with alcohol use disorder: Secondary analysis of a randomized clinical trial.
    Hoffman SN; Lyons RC; Stein MB; Taylor CT; Norman SB
    Behav Res Ther; 2022 Aug; 155():104097. PubMed ID: 35696838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seeking Safety treatment for male veterans with a substance use disorder and post-traumatic stress disorder symptomatology.
    Boden MT; Kimerling R; Jacobs-Lentz J; Bowman D; Weaver C; Carney D; Walser R; Trafton JA
    Addiction; 2012 Mar; 107(3):578-86. PubMed ID: 21923756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans.
    Gros DF; Lancaster CL; Horner MD; Szafranski DD; Back SE
    Compr Psychiatry; 2017 Oct; 78():48-53. PubMed ID: 28803041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of attendance in outpatient group treatment for women with posttraumatic stress disorder and substance use disorder.
    Grundmann J; Lotzin A; Sehner S; Verthein U; Hiller P; Hiersemann R; Lincoln TM; Hillemacher T; Schneider B; Driessen M; Scherbaum N; Dotten AC; Schäfer I
    Psychother Res; 2021 Jun; 31(5):632-643. PubMed ID: 32930057
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical presentations, social functioning, and treatment receipt among individuals with comorbid life-time PTSD and alcohol use disorders versus drug use disorders: findings from NESARC-III.
    Simpson TL; Rise P; Browne KC; Lehavot K; Kaysen D
    Addiction; 2019 Jun; 114(6):983-993. PubMed ID: 30694592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans.
    Back SE; Flanagan JC; Killeen T; Saraiya TC; Brown DG; Jarnecke AM; Rothbaum AO; Joseph J; Ana ES; de Arellano A; Shoemaker HL; Dixon RA; Nietert PJ; Brady KT
    Contemp Clin Trials; 2023 Mar; 126():107084. PubMed ID: 36646315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Exposure-Based Risk Reduction Through Family Therapy for Co-occurring Substance Use Problems and Posttraumatic Stress Disorder Symptoms Among Adolescents: A Randomized Clinical Trial.
    Danielson CK; Adams Z; McCart MR; Chapman JE; Sheidow AJ; Walker J; Smalling A; de Arellano MA
    JAMA Psychiatry; 2020 Jun; 77(6):574-586. PubMed ID: 32022827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in protective factors among U.S. Veterans with posttraumatic stress disorder, alcohol use disorder, and their comorbidity: Results from the National Health and Resilience in Veterans Study.
    Straus E; Norman SB; Haller M; Southwick SM; Hamblen JL; Pietrzak RH
    Drug Alcohol Depend; 2019 Jan; 194():6-12. PubMed ID: 30390551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders.
    Kehle-Forbes SM; Chen S; Polusny MA; Lynch KG; Koffel E; Ingram E; Foa EB; Van Horn DHA; Drapkin ML; Yusko DA; Oslin DW
    Drug Alcohol Depend; 2019 Dec; 205():107647. PubMed ID: 31675546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Attendance Among Veterans With Depression, Substance Use Disorder, and Trauma.
    Cui R; Haller M; Skidmore JR; Goldsteinholm K; Norman S; Tate SR
    J Dual Diagn; 2016; 12(1):15-26. PubMed ID: 26828770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient- and therapist-rated alliance predict improvements in posttraumatic stress disorder symptoms and substance use in integrated treatment.
    Saraiya TC; Jarnecke AM; Bauer AG; Brown DG; Killeen T; Back SE
    Clin Psychol Psychother; 2023 Mar; 30(2):410-421. PubMed ID: 36509681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.